Trading Signals: EDIT Stock Price Prediction and Forecast (Wed. Feb. 3, 2016 - Fri. Dec. 22, 2023)(EDITAS MEDICIN)
| EDIT latest price $8.4000 (-6.77%) ($8.4000 - $8.4000) on Wed. Nov. 8, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.28% (three month average) | RSI | 74 | Latest Price | $8.4000(-6.77%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | EDIT advances 3.9% a day on average for past five trading days. | Weekly Trend | EDIT advances 14.6% a week on average for past two weeks. | Market Behavior | Normal for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support EDIT advance at 0% a week (0% probability) ARKG(81%) XBI(80%) ARKK(70%) IBUY(68%) IBB(67%) | Factors Impacting EDIT price | EDIT will decline at least -2.14% in a week (0% probabilities). TBT(-25%) VXX(-14%) UUP(-12%) VIXM(-0%) USO(5%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | | | | Market Trend Strength | -2.14% (StdDev 4.28%) | Hourly BBV | -0.4 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $8.23(2.07%) | 10 Day Moving Average | $7.44(12.9%) | 20 Day Moving Average | $7.05(19.15%) | To recent high | -8% | To recent low | 34.2% | Market Cap | $522m | | | | Editas Medicine, Inc. engages in the development and commercialization of genome editing technology. Its technology includes clustered, regularly interspaced short palindromic repeats (CRISPR), and CRISPR associated protein 9 (Cas9). The company was founded by Feng Zhang, Jennifer A. Doudna, George McDonald Church, J. Keith Joung and David R. Liu in September 2013 and is headquartered in Cambridge, MA. |